Quick Answer
MANGOCEUTICALS, INC. reported Cash and Equivalents of $58.7 thousand for fiscal year 2024.
MANGOCEUTICALS, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $58.7K | -92.1% |
| 2023 | $739.0K | +8.2% |
| 2022 | $682.9K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $481.3K | +551.2% | +376.4% |
| June 30, 2025 | $101.0K | -79.4% | +32.1% |
| March 31, 2025 | $76.5K | +399.8% | +30.4% |
| December 31, 2024 | $58.7K | -92.1% | -20.6% |
| September 30, 2024 | $73.9K | -94.0% | -84.9% |
| June 30, 2024 | $490.2K | — | +3103.2% |
| March 31, 2024 | $15.3K | — | -97.9% |
| December 31, 2023 | $739.0K | +8.2% | -40.2% |
- MANGOCEUTICALS, INC. showed a decrease of -92.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2022–2024 period, MANGOCEUTICALS, INC.’s cash and equivalents has declined by 91.4% (from $682.9 thousand to $58.7 thousand).
- The most recent figure is from MANGOCEUTICALS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 20, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: